InspireMD, Inc.
NSPR
$2.56
-$0.10-3.76%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.01M | 6.82M | 6.57M | 6.48M | 6.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.01M | 6.82M | 6.57M | 6.48M | 6.21M |
| Cost of Revenue | 5.50M | 5.28M | 5.00M | 4.75M | 4.40M |
| Gross Profit | 1.51M | 1.54M | 1.57M | 1.73M | 1.81M |
| SG&A Expenses | 21.38M | 19.51M | 18.52M | 17.14M | 14.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.51M | 36.77M | 33.69M | 30.65M | 27.35M |
| Operating Income | -33.50M | -29.94M | -27.12M | -24.18M | -21.14M |
| Income Before Tax | -31.95M | -28.17M | -25.46M | -22.63M | -19.85M |
| Income Tax Expenses | 59.00K | 65.00K | 65.00K | 65.00K | 65.00K |
| Earnings from Continuing Operations | -32.01 | -28.24 | -25.52 | -22.69 | -19.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.01M | -28.24M | -25.52M | -22.69M | -19.92M |
| EBIT | -33.50M | -29.94M | -27.12M | -24.18M | -21.14M |
| EBITDA | -33.22M | -29.68M | -26.87M | -23.93M | -20.91M |
| EPS Basic | -0.78 | -0.75 | -0.74 | -0.76 | -1.08 |
| Normalized Basic EPS | -0.47 | -0.46 | -0.45 | -0.47 | -0.67 |
| EPS Diluted | -0.78 | -0.75 | -0.74 | -0.76 | -1.08 |
| Normalized Diluted EPS | -0.47 | -0.46 | -0.45 | -0.47 | -0.67 |
| Average Basic Shares Outstanding | 167.38M | 152.12M | 137.73M | 122.93M | 96.78M |
| Average Diluted Shares Outstanding | 167.38M | 152.12M | 137.73M | 122.93M | 96.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
